The Food and Drug Administration has approved 2 new oral antibiotics for the treatment of uncomplicated gonorrhea, expanding therapeutic options amid growing drug resistance. Zoliflodacin was approved based on results from a multinational phase 3 trial involving 930 patients. In the study, a single oral dose of zoliflodacin was noninferior to a regimen of injectable ceftriaxone plus oral azithromycin. The study showed 91% of patients who took zoliflodacin were cured, and 96% of patients who …
Read More